TrialThe Prostate2015

Safety of enzalutamide in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: expanded access in North America.

Anthony M Joshua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.